StonvexLoading…
StonvexStonvexStonvexCore line items from MCHB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|---|
Revenue | $209.53M | $13.02M | $49.73M | $35.67M | $11.50M |
Operating Income | Not available | $61.87M | $319.55M | $165.60M | $61.45M |
Net Income | Not available | $44.09M | $265.74M | $141.44M | $43.79M |
EPS (Diluted) | $0.27 | $0.20 | $1.27 | $0.69 | $0.22 |
Total Assets | Not available | $21.39B | $22.35B | $22.71B | $7.80B |
Total Liabilities | Not available | $18.60B | $19.49B | $19.93B | $7.40B |
Cash & Equivalents | Not available | $483.51M | $1.03B | $1.44B | $252.16M |
Free Cash Flow OCF − CapEx | Not available | $8.76M | $187.08M | $76.65M | $-1.94M |
Shares Outstanding | Not available | 222.32M | 208.73M | 204.19M | 18.92M |